Abera Bioscience AB (NGM:ABERA)
5.90
+0.10 (1.72%)
At close: Nov 14, 2025
Abera Bioscience AB Revenue
Abera Bioscience AB had revenue of 4.30M SEK in the quarter ending June 30, 2025, a decrease of -4.64%. This brings the company's revenue in the last twelve months to 15.72M, up 69.90% year-over-year. In the year 2024, Abera Bioscience AB had annual revenue of 14.63M with 479.60% growth.
Revenue (ttm)
15.72M
Revenue Growth
+69.90%
P/S Ratio
6.92
Revenue / Employee
3.14M
Employees
5
Market Cap
108.84M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 14.63M | 12.11M | 479.60% |
| Dec 31, 2023 | 2.52M | 736.19K | 41.18% |
| Dec 31, 2022 | 1.79M | 609.91K | 51.78% |
| Dec 31, 2021 | 1.18M | 422.43K | 55.92% |
| Dec 31, 2020 | 755.48K | -745.52K | -49.67% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AB Volvo | 493.79B |
| Telefonaktiebolaget LM Ericsson | 240.31B |
| H & M Hennes & Mauritz AB | 231.26B |
| Atlas Copco AB | 171.55B |
| ASSA ABLOY AB | 153.68B |
| Investor AB | 133.31B |
| Sandvik AB | 120.37B |
| Skandinaviska Enskilda Banken AB | 76.49B |